Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | MG5S9 | — |
nurse that got the Shingrix vaccine in her eye while handling it; nurse that got the Shingrix vaccine in her eye while handling it; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of occupational exposure to product via eye in a female patient who received Herpes zoster (Shingrix) (batch number MG5S9, expiry date 30-MAR-2027) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced occupational exposure to product via eye (Verbatim: nurse that got the Shingrix vaccine in her eye while handling it) and inadvertent exposure to vaccine (Verbatim: nurse that got the Shingrix vaccine in her eye while handling it). The outcome of the occupational exposure to product via eye and inadvertent exposure to vaccine were not applicable. Additional Information: GSK Receipt Date: 16-JUN-2025 and 17-JUN-2025 The Vaccine Administration Facility was the same as Primary Reporter On 16 June 2025, a pharmacist from Healthcare Center called to report the incident of a nurse that got the Shingrix vaccine in her eye while handling it which led to occupational exposure to product via eye and inadvertent exposure to vaccine. According to the health care provider, the nurse had already washed her eye with water, but he wanted to have an updated version of the Safety Data Sheet for Shingrix since they had an old version, and in consequence for knowing how to proceed in case of eye contact. The pharmacist got the information about the nurse and the vaccine and commented that she was feeling better after washing her eye with water.